Arda Therapeutics
Latest round
- Series A
Last raised
- Sep 2024
Total raised
- $51M
Investors
- 13
About Arda Therapeutics
Founded in 2021 and based in California, US, Arda Therapeutics, Inc. operates as a biotechnology company that offers drug development solutions. The company was founded by its CEO, Adam Freund, and CTO, Remi-Martin Laberge. In September 2024, Arda Therapeutics, Inc. Arda Therapeutics develops therapies that target and eliminate specific disease-causing cells. Using single-cell data analysis, the company identifies pathogenic cells responsible for the diseases and pinpoints specific markers on these cells for targeted therapy. The firm designs cell therapies that specifically target these markers and eliminate only the pathogenic cells.
Who invested in Arda Therapeutics
13 investors across 2 rounds
See all investors in Arda Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Arda Therapeutics
Who invested in Arda Therapeutics?
Arda Therapeutics has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Arda Therapeutics raised?
Arda Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Arda Therapeutics last raise money?
Arda Therapeutics's most recent round on record is a Series A, in Sep 2024.
What does Arda Therapeutics do?
Founded in 2021 and based in California, US, Arda Therapeutics, Inc.
Where is Arda Therapeutics headquartered?
Arda Therapeutics is headquartered in San Carlos, US.
Which VCs invest in companies like Arda Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Arda Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Arda Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.